1.Effect of L - Shape Cytobrush in the Cervical Pap Smear.
Korean Journal of Obstetrics and Gynecology 2000;43(9):1557-1563
No abstract available.
2.Radiofrequency Treatment for Chronic Refractory Pain.
Jung Yul PARK ; Dong Hyuk PARK
Journal of the Korean Geriatrics Society 2001;5(4):285-301
Radiofrequcy(RF) treatment has a long history, more than hundred years, for the management of chronic intractable pain of various causes. With better understanding of pain mechanism and advancement of technology, along with previous valuable experience, a simpler and safer method of delivering RF thermo coagulation to ideal sites are now available that can be expected to provide more beneficial effects to these patients with chronic disabling pain. This type of treatment will be especially helpful in aged in whom surgery is often contraindicated or highly risky due to medical problems. Here, using up-to-dated, evidence based knowledge and personal experience, authors have tried to introduce briefly the history and basic mechanism of RF technique and various clinical situations where this type of therapy is currently known to be indicated or effective in providing substantial pain relief. In summary, the RF thermocoagulation is proven to be effective way of providing significant pain relief in many chronic refractory pain states with numerous advantages such as minimal invasive, quantitative lesioning with temperature-controlled, well-circumscription of lesions, simplicity and feasibility of procedure, and most of all safety and cost-effectiveness. When it is selected based on careful investigation on type and cause of pain it can be expected to provide relatively long duration of pain relief and also to help to recover functional disabilities from such pain. However, judicious use is warranted because some painful conditions are known to be ineffective or contraindicated from this type of therapy and because there are possible serious complications, although very few. Use of latest technique of pulsed, high-frequency, low-temperatured thermocoagulation will possibly bring hope and new insights in the management of chronic intractable pain of neuropathic in nature. Further research and experience will be required before justifying this type of therapy in appling broader and more challenging situations.
Electrocoagulation
;
Hope
;
Humans
;
Neuralgia
;
Pain, Intractable*
3.Letter from Editor.
Hoon HUR ; Hyo Jung PARK ; Hyuk Joon LEE
Journal of Clinical Nutrition 2017;9(1):1-1
No abstract available.
4.Letter form Editor.
Hoon HUR ; Hyo Jung PARK ; Hyuk Joon LEE
Journal of Clinical Nutrition 2017;9(2):37-37
No abstract available.
5.Neuroendocrine immunoperoxidase markers to predict chemotherapy response in lung cancer patients.
Hyuk JUNG ; Sang Jae LEE ; Un Sub PARK
Journal of the Korean Cancer Association 1993;25(5):664-672
No abstract available.
Drug Therapy*
;
Humans
;
Lung Neoplasms*
;
Lung*
6.Letter from Editor.
Hoon HUR ; Hyo Jung PARK ; Hyuk Joon LEE
Journal of Clinical Nutrition 2016;8(3):71-71
No abstract available.
7.Letter from Editor.
Hoon HUR ; Hyo Jung PARK ; Hyuk Joon LEE
Journal of Clinical Nutrition 2018;10(1):1-1
No abstract available.
8.A Case of Perigraft Seroma in Chronic Hemodialysis Patient.
Ji Hoon KIM ; Hae Hyuk JUNG ; Kyoung Hyoub MOON ; In Suk SONG ; Jung Sik PARK
Korean Journal of Nephrology 1999;18(3):510-512
Perigraft seroma is uncommon complication of polytetrafluoroethylene(PTFE) grafts applied as an arteriovenous shunt for hemodialysis. It is a collection of clear, sterile fluid confined to nonsecretory fibrous pseudomembrane, most commonly localized around the middle and distal portion of graft. The possible etiologic factors of perigraft seroma include poor graft incorporation, mechanical graft damage caused by alcohol and povidone-iodine, intraoperative streching of the graft, variations in quality control at the time of manufacture and contributing factors such as anemia and coagulopathy in uremia. The best strategy for management of perigraft seroma is not clear. spiration or drainage alone is not effective, and some authors advocate graft removal. We report a case of perigraft seroma around arterial end of PTFE graft along with a brief review of the literatures.
Anemia
;
Drainage
;
Humans
;
Polytetrafluoroethylene
;
Povidone-Iodine
;
Quality Control
;
Renal Dialysis*
;
Seroma*
;
Transplants
;
Uremia
9.Consensus for the Treatment of Varicose Vein with Radiofrequency Ablation.
Jin Hyun JOH ; Woo Shik KIM ; In Mok JUNG ; Ki Hyuk PARK ; Taeseung LEE ; Jin Mo KANG
Vascular Specialist International 2014;30(4):105-112
The objective of this paper is to introduce the schematic protocol of radiofrequency (RF) ablation for the treatment of varicose veins. Indication: anatomic or pathophysiologic indication includes venous diameter within 2-20 mm, reflux time > or =0.5 seconds and distance from the skin > or =5 mm or subfascial location. Access: it is recommended to access at or above the knee joint for great saphenous vein and above the mid-calf for small saphenous vein. Catheter placement: the catheter tip should be placed 2.0 cm inferior to the saphenofemoral or saphenopopliteal junction. Endovenous heat-induced thrombosis > or =class III should be treated with low-molecular weight heparin. Tumescent solution: the composition of solution can be variable (e.g., 2% lidocaine 20 mL+500 mL normal saline+bicarbonate 2.5 mL with/without epinephrine). Infiltration can be done from each direction. Ablation: two cycles' ablation for the first proximal segment of saphenous vein and the segment with the incompetent perforators is recommended. The other segments should be ablated one time. During RF energy delivery, it is recommended to apply external compression. Concomitant procedure: It is recommended to do simultaneously ambulatory phlebectomy. For sclerotherapy, it is recommended to defer at least 2 weeks. Post-procedural management: post-procedural ambulation is encouraged to reduce the thrombotic complications. Compression stocking should be applied for at least 7 days. Minor daily activity is not limited, but strenuous activities should be avoided for 2 weeks. It is suggested to take showers after 24 hours and tub baths, swimming, or soaking in water after 2 weeks.
Baths
;
Catheter Ablation*
;
Catheters
;
Consensus*
;
Heparin
;
Knee Joint
;
Lidocaine
;
Saphenous Vein
;
Sclerotherapy
;
Skin
;
Stockings, Compression
;
Swimming
;
Thrombosis
;
Varicose Veins*
;
Walking
10.The review of laparoscopic adnexa tumor surgery through Douglas pouch.
Korean Journal of Gynecologic Endoscopy and Minimally Invasive Surgery 2012;24(2):115-119
OBJECTIVE: To evaluated the result of laparoscopic surgery of adnexal tumors and removing excised tissue through Douglas pouch incision. METHODS: 110 patient who had visited Chosun University Hospital department of Obstetrics and Gynecology between January, 2011 to April, 2012 were involved in the study. Patient had laparoscopic surgery on the adnexal tumor and excised tissue was removed through Douglas pouch incision by single surgeon. RESULTS: The mean age of patients were 41.5 years. The size of the tumor varied from 3 cm to 27 cm in size using ultrasonography. The mean operation time was 61.3 minutes and the mean admission period was 4.2 days. 82 patient had salpingo-oophorectomy or oophorectomy, 19 had ovarian cystectomy, 2 had wedge resection and 4 had tumor enucleation. Histologic result reveal endometriosis in 23 patients (20.9%). teratoma in 21 (19%), serous cystadenoma in 14 (12.7%) and mucinous cystadenoma in 10 (9.1%). Other histologic finding includes hemorrhagic cyst, luteal cyst and paratubal cyst. There was no complication including bladder or rectal injury, suture site infection. CONCLUSION: Laparoscopic surgery of adnexal tumor and removal by Douglas pouch incision is a simple, safe and efficient method that could be considered as an alternative minimally invasive technique.
Cystadenoma, Mucinous
;
Cystadenoma, Serous
;
Cystectomy
;
Douglas' Pouch
;
Endometriosis
;
Female
;
Gynecology
;
Hospital Departments
;
Humans
;
Laparoscopy
;
Obstetrics
;
Ovariectomy
;
Parovarian Cyst
;
Sutures
;
Teratoma
;
Urinary Bladder